Tyra Biosciences Inc (TYRA) — Financial Flexibility Index
Tyra Biosciences Inc (TYRA) has a Financial Flexibility Index of -1.01x as of December 2025. Free cash flow of $-23.57 Million (operating CF $-23.62 Million minus capex $57.00K) represents -1% of total liabilities ($23.43 Million). Check TYRA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tyra Biosciences Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Tyra Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see Tyra Biosciences Inc (TYRA) cash flow conversion.
Annual Financial Flexibility Index for Tyra Biosciences Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Tyra Biosciences Inc. Explore TYRA debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -4.05x | $-95.00 Million | $-95.14 Million | $23.43 Million | ▼ -19.7% |
| 2024 | -3.39x | $-69.11 Million | $-69.77 Million | $20.41 Million | ▼ -48.1% |
| 2023 | -2.29x | $-49.37 Million | $-50.14 Million | $21.59 Million | ▲ +61.6% |
| 2022 | -5.95x | $-49.73 Million | $-50.28 Million | $8.35 Million | ▼ -28.0% |
| 2021 | -4.65x | $-23.08 Million | $-23.75 Million | $4.96 Million | ▼ -1750.4% |
| 2020 | -0.25x | $-7.45 Million | $-7.76 Million | $29.65 Million | ▲ +49.0% |
| 2019 | -0.49x | $-2.60 Million | $-2.62 Million | $5.27 Million | — |